Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.930,69
1,66%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Dr Reddys Laboratories Ltd (RDY) Dr Reddys Laboratories Ltd (RDY) Notizie

Dr Reddys Laboratories Ltd

RDY
75,21
0,43 (0,58%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
03/5/202414:00BWDr. Reddy's Laboratories Announces the Launch of Doxycycline..
22/3/202412:00GLOBEPharmazz Inc. and Dr. Reddy's Laboratories have entered into..
19/3/202412:00BWDr. Reddy's Laboratories launches Versavo® (bevacizumab) in..
04/3/202412:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/3/202412:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/2/202412:57EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/2/202412:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/2/202412:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/2/202412:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/2/202414:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/2/202412:20EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/2/202412:39EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/2/202418:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/2/202416:53EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/2/202412:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/1/202415:44BWDr. Reddy’s Q3 & 9M FY24 Financial Results
31/1/202413:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/1/202420:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/1/202419:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/1/202417:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/1/202412:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/1/202416:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/1/202419:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/1/202417:34EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/1/202414:58DJNIndian Dr. Reddy's in Talks to Buy Haleon's Nicotinell, Sky..
16/1/202412:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/1/202414:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/1/202412:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/1/202412:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/1/202412:00BWDr. Reddy's Announces the Acquisition of MenoLabs®, a..
02/1/202412:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/1/202412:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/12/202314:39EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/12/202313:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/12/202312:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/12/202312:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/12/202313:49BWDr. Reddy’s becomes first Indian pharma company to debut on..
12/12/202312:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/12/202312:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/12/202318:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/12/202317:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/12/202313:55DJNCoya Therapeutics Strikes Development, Commercialization..
06/12/202313:00BWCoya Therapeutics, Inc. and Dr. Reddy’s Laboratories Enter..
01/12/202313:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/11/202314:59EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/11/202313:38EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/11/202313:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/11/202315:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/11/202314:49EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/11/202312:49EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
Apertura: 74,89 Min: 74,705 Max: 75,43
Chiusura: 74,78

La tua Cronologia

NYSE
RDY
Dr Reddys Laboratories
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network